170 related articles for article (PubMed ID: 31412816)
1. G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer.
Ahn JI; Yoo JY; Kim TH; Kim YI; Broaddus RR; Ahn JY; Lim JM; Jeong JW
BMC Cancer; 2019 Aug; 19(1):810. PubMed ID: 31412816
[TBL] [Abstract][Full Text] [Related]
2. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
3. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
4. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
5. GRP78 mediates cell growth and invasiveness in endometrial cancer.
Calì G; Insabato L; Conza D; Bifulco G; Parrillo L; Mirra P; Fiory F; Miele C; Raciti GA; Di Jeso B; Terrazzano G; Beguinot F; Ulianich L
J Cell Physiol; 2014 Oct; 229(10):1417-26. PubMed ID: 24526410
[TBL] [Abstract][Full Text] [Related]
6. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JE; Holst J
Int J Cancer; 2016 Dec; 139(11):2529-39. PubMed ID: 27486861
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
[TBL] [Abstract][Full Text] [Related]
9. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
10. The role of relaxin in endometrial cancer.
Kamat AA; Feng S; Agoulnik IU; Kheradmand F; Bogatcheva NV; Coffey D; Sood AK; Agoulnik AI
Cancer Biol Ther; 2006 Jan; 5(1):71-7. PubMed ID: 16322684
[TBL] [Abstract][Full Text] [Related]
11. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
12. Rap1GAP inhibits tumor progression in endometrial cancer.
Tamate M; Tanaka R; Osogami H; Matsuura M; Satohisa S; Iwasaki M; Saito T
Biochem Biophys Res Commun; 2017 Apr; 485(2):476-483. PubMed ID: 28196746
[TBL] [Abstract][Full Text] [Related]
13. Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2.
He YY; Du GQ; Cai B; Yan Q; Zhou L; Chen XY; Lu W; Yang YX; Wan XP
J Cancer Res Clin Oncol; 2012 May; 138(5):775-83. PubMed ID: 22270964
[TBL] [Abstract][Full Text] [Related]
14. Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer.
Fue M; Miki Y; Takagi K; Hashimoto C; Yaegashi N; Suzuki T; Ito K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126180
[TBL] [Abstract][Full Text] [Related]
15. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
16. Lnc-NA inhibits proliferation and metastasis in endometrioid endometrial carcinoma through regulation of NR4A1.
Sun L; Zhou R; Dong J; Liu S; Jiao Y; Wang L; Hu S; He P; Liu X; Zhao X; Jiang G; Zhao Y
J Cell Mol Med; 2019 Jul; 23(7):4699-4710. PubMed ID: 31050196
[TBL] [Abstract][Full Text] [Related]
17. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer.
Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P
J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607
[TBL] [Abstract][Full Text] [Related]
18. G-protein coupled receptor 64 is required for decidualization of endometrial stromal cells.
Yoo JY; Ahn JI; Kim TH; Yu S; Ahn JY; Lim JM; Jeong JW
Sci Rep; 2017 Jul; 7(1):5021. PubMed ID: 28694502
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
[TBL] [Abstract][Full Text] [Related]
20. miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma.
Su N; Qiu H; Chen Y; Yang T; Yan Q; Wan X
Oncol Rep; 2013 Jun; 29(6):2297-302. PubMed ID: 23589079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
